Rezultati - Hartmut Link

Refine Results
  1. 1
    Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)

    Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF) od Hartmut Link

    Izdano 2022
    Polni tekst Polni tekst
    Editorial
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Transplantation of allogeneic CD34+ blood cells

    Transplantation of allogeneic CD34+ blood cells od Hartmut Link, Lubomir Arseniev, O Bahre, JG Kadar, H. Diedrich, H. Poliwoda

    Izdano 1996
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Supportive Treatments for Patients with Cancer

    Supportive Treatments for Patients with Cancer od Karin Jordan, Petra Feyer, Ulrike Höller, Hartmut Link, Bernhard Wörmann, Franziska Jahn

    Izdano 2017
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

    Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study od Georg Maschmeyer, Hartmut Link, Wolfgang Hiddemann, Peter Meyer, M. Helmerking, Edith Eisenmann, Josef Schmitt, Dieter Adam

    Izdano 1994
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    A controlled trial of recombinant human erythropoietin after bone marrow transplantation

    A controlled trial of recombinant human erythropoietin after bone marrow transplantation od Hartmut Link, MA Boogaerts, AA Fauser, S Slavin, J Reiffers, NC Gorin, Carella Am, Franco Mandelli, Stefan Burdach, Augustin Ferrant

    Izdano 1994
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma

    A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplan... od Hartmut Link, MA Boogaerts, Carella Am, Augustin Ferrant, Helmut Gadner, NC Gorin, I. Harabacz, JL Harousseau, P Hervé, Johanna Holldack

    Izdano 1992
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

    Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group od Pierre Fenaux, M. Le Deley, Sylvie Castaigné, E Archimbaud, Christine Chomienne, Hartmut Link, A. Guerci, M Duarte, MT Daniel, Deborah A. Bowen

    Izdano 1993
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

    Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations od Matti Aapro, Ralph V. Boccia, Robert Leonard, Carlos Camps, Mario Campone, Sylvain Choquet, Marco Danova, John A. Glaspy, Iwona Hus, Hartmut Link, Thamer Sliwa, Hans Tesch, Vicente Valero

    Izdano 2017
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer

    A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer od Alexander Schmittel, Martin Sebastian, Ludwig Fischer von Weikersthal, Peter Martus, Thomas Gauler, Christoph C. Kaufmann, P. Hortig, J.R. Fischer, Hartmut Link, D. Binder, B. Fischer, K Caca, Wilfried Eberhardt, Ulrich Keilholz

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

    Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines od Matti Aapro, Yves Béguin, Carsten Bokemeyer, Mario Dicato, Pere Gascón, John A. Glaspy, Axel Hofmann, Hartmut Link, T. Littlewood, Heinz Ludwig, Anders Österborg, P. Pronzato, Valeria Santini, D. Schrijvers, R. Stauder, Kim Jordan, Jørn Herrstedt

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Iron metabolism and iron supplementation in cancer patients

    Iron metabolism and iron supplementation in cancer patients od Heinz Ludwig, Rayko Evstatiev, Gabriela Kornek, Matti Aapro, Thomas Bauernhofer, Veronika Buxhofer‐Ausch, Michael Fridrik, D. Geißler, Klaus Geißler, Heinz Gisslinger, Elisabeth Koller, Gerhard Kopetzky, Alois Lang, Holger Rumpold, Michael Steurer, Houman Kamali, Hartmut Link

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

    Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial od G. Huebner, Hartmut Link, C.-H. Köhne, Michael Stahl, Albrecht Kretzschmar, Silke Steinbach, Gunnar Folprecht, H. Bernhard, Salah‐Eddin Al‐Batran, Patrick Schöffski, Christoph Burkart, Frank Kullmann, Burkhard Otremba, M Menges, Martin Hoffmann, Ulrich Kaiser, Ali Aldaoud, Andreas Jahn

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

    Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 10... od Hannes Wandt, Markus H. Frank, Gerhard Ehninger, Christiane Schneider, N. Brack, Ali Daoud, I. Fackler-Schwalbe, J.T. Fischer, Ringfried Gäckle, Thomas Geer, P. Harms, B. Löffler, S. Öhl, Burkhard Otremba, Monika Raab, Petra Schönrock-Nabulsi, Gerhard Strobel, Rolf Winter, Hartmut Link

    Izdano 1998
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society... od Werner Heinz, Dieter Buchheidt, Maximilian Christopeit, Marie von Lilienfeld‐Toal, Oliver A. Cornely, Hermann Einsele, Meinolf Karthaus, Hartmut Link, Rolf Mahlberg, Silke Neumann, Helmut Ostermann, Olaf Penack, Markus Ruhnke, Michael Sandherr, Xaver Schiel, Jörg Janne Vehreschild, Florian Weißinger, Georg Maschmeyer

    Izdano 2017
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies

    Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies od Hermann Einsele, Hartmut Bertz, J. Beyer, Michael Kiehl, Volker Runde, Hans-Jochen Kölb, Ernst Holler, Robert Beck, Rainer Schwerdfeger, Ulrike Schumacher, Holger Hebart, Hans Martin, Joachim Kienast, Andrew J. Ullmann, Georg Maschmeyer, William Krüger, Dietger Niederwieser, Hartmut Link, Christian Schmidt, Helmut Oettle, Thomas Klingebiel

    Izdano 2003
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology... od Sabine Mousset, Dieter Buchheidt, Werner Heinz, Markus Ruhnke, Oliver A. Cornely, Gerlinde Egerer, William Krüger, Hartmut Link, Silke Neumann, Helmut Ostermann, Jens Panse, Olaf Penack, Christina Rieger, Martin Schmidt‐Hieber, Gerda Silling, Thomas Südhoff, Andrew J. Ullmann, Hans‐Heinrich Wolf, Georg Maschmeyer, Angelika Böhme

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

    Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer.... od C.-H. Köhne, Jacques De Grève, J. T. Hartmann, István Láng, Philippe Vergauwe, Karl‐Friedrich Becker, D. Braumann, E. Joosens, Lothar Müller, Jos Janssens, Carsten Bokemeyer, Peter Reimer, Hartmut Link, E. Späth‐Schwalbe, H. Wilke, Harry Bleiberg, Jan Van den Brande, Muriel Debois, Ullrich Bethe, Eric Van Cutsem

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase

    Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase od Mohamad Jawhar, Nicole Naumann, Juliana Schwaab, H. Baurmann, Jochen Casper, Tu‐Anh Dang, Lutz Dietze, Konstanze Döhner, Annette Hänel, B. Lathan, Hartmut Link, Sina Lotfi, Ole Maywald, Stephan Mielke, Lothar Müller, Uwe Platzbecker, Otto Prümmer, Henrike Thomssen, Karin Töpelt, Jens Panse, Tom Vieler, Wolf‐Karsten Hofmann, Torsten Haferlach, Claudia Haferlach, Alice Fabarius, Andreas Hochhaus, Nicholas C.P. Cross, Andreas Reiter, Georgia Metzgeroth

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL

    S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009... od Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, Jann Arends, Dirk Arnold, Gustavo Baretton, Jan Bornschein, Wilfried Budach, S Daum, Christoph G. Dietrich, Matthias Ebert, Wolfgang Fischbach, Michael Flentje, Ines Gockel, Lars Grenacher, Jörg Haier, Stefan Höcht, R Jakobs, Christian Jenssen, Barbara Kade, S Kanzler, Jost Langhorst, Hartmut Link, Florian Lordick, Dietmar Lorenz, Sylvie Lorenzen, Manfred P. Lutz, Helmut Messmann, Hans‐Joachim Meyer, Stefan Mönig, Katja Ott, Michael Quante, Christoph Röcken, Peter Schlattmann, Wolff-H. Schmiegel, A. Schreyer, Andrea Tannapfel, Peter Thuss‐Patience, Arved Weimann, Susanne Unverzagt

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

    Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial od Christoph Röllig, Hubert Serve, Richard Noppeney, Maher Hanoun, Utz Krug, Claudia D. Baldus, Christian Brandts, Volker Kunzmann, Hermann Einsele, Alwin Krämer, Carsten Müller‐Tidow, Kerstin Schäfer‐Eckart, Andreas Neubauer, Andreas Burchert, Aristoteles Giagounidis, Stefan W. Krause, Andréas Mackensen, Walter E. Aulitzky, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Johannes Kullmer, Ulrich Kaiser, Alexander Kiani, Hartmut Link, Thomas Geer, Albrecht Reichle, Christian Junghanß, Roland Repp, Achim Meinhardt, Heinz Dürk, Ina‐Maria Klut, Martin Bornhäuser, Markus Schaich, Stefani Parmentier, Martin Görner, Christian Thiede, Malte von Bonin, Uwe Platzbecker, Johannes Schetelig, Michael Krämer, Wolfgang E. Berdel, Gerhard Ehninger

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: